Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Pantec Biosolutions

January 17, 2013
Pantec Presents Case Studies for Dermatological and Aesthetic Applications of P.L.E.A.S.E. Professio
Pantec Biosolutions AG shows, in a new series of “before and after” case study images, the versatility and effectiveness of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility in dermatological and aesthetic applications. More

February 8, 2011
Pantec Biosolutions reports first successful IVF pregnancy using P.L.E.A.S.E. –FSH patch
Pantec Biosolutions AG, a privately-owned company developing innovative transdermal drug delivery products, announced today that a woman has successfully conceived after being implanted with a fertilized oocyte (egg cell). More

June 1, 2010
Pantec Biosolutions’ P.L.E.A.S.E. Professional receives marketing authorisation
Pantec Biosolutions AG, a company developing innovative technologies for transdermal drug delivery, has received a CE mark in the EU for the new professional product line of the company’s transdermal delivery device: P.L.E.A.S.E. (Painless Laser Epidermal System). More

September 24, 2009
Pantec Biosolutions granted European patent for P.L.E.A.S.E
Pantec Biosolutions AG, a privately-owned company developing innovative transdermal drug delivery products, announced today that it has been granted European Patent No. EP1874213, entitled ‘LASER MICROPORATOR’ by the European Patent Office. More

April 20, 2009
Pantec Biosolutions reports successful Phase I study into the delivery of triptorelin
Pantec Biosolutions reports successful Phase I study into the delivery of triptorelin using P.L.E.A.S.E. technology More

December 1, 2008
Pantec Biosolutions receives marketing clearance for P.L.E.A.S.E.
Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, today announced that it has received CE marking for the company’s lead product P.L.E.A.S.E. More

September 24, 2008
Pantec Biosolutions receives ISO 13485 certification
Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, today announced that it has successfully established a Quality Management System (QMS) in accordance with ISO 13485:2003 standards for medical devices. More

May 15, 2008
Pantec Biosolutions appoints new Board members
Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, today announces the appointment of Burkhard Feurstein and Michael Armbruester to the Board following their election at the annual shareholders meeting held on April 24, 2008. More

April 2, 2008
Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform
Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, reports promising preclinical in vitro data in support of the company’s novel P.L.E.A.S.E. intraepidermal drug delivery platform. More

January 16, 2008
Pantec Biosolutions presents new drug delivery platform and supporting preclinical data
Pantec Biosolutions presents new drug delivery platform and supporting preclinical data at Drug Delivery Partnerships 2008, San Diego, USA More

Data


26,008
Tech investments
From our Online Data Service
16,823
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Aug 19€7.0MAgriculture related
Aug 19€9.0MInternet commerce
Aug 19€10.0ME-Commerce
Aug 19€63.0MBusiness applications
Aug 16€16.0ME-Commerce
Aug 16€6.0MBusiness applications
Aug 15€20.0MGames

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.